Hemoprotein Catalyzed Oxygenations: P450s, UPOs, and Progress toward Scalable Reactions

JACS Au. 2021 Jul 26;1(9):1312-1329. doi: 10.1021/jacsau.1c00251. eCollection 2021 Sep 27.


The selective oxygenation of nonactivated carbon atoms is an ongoing synthetic challenge, and biocatalysts, particularly hemoprotein oxygenases, continue to be investigated for their potential, given both their sustainable chemistry credentials and also their superior selectivity. However, issues of stability, activity, and complex reaction requirements often render these biocatalytic oxygenations problematic with respect to scalable industrial processes. A continuing focus on Cytochromes P450 (P450s), which require a reduced nicotinamide cofactor and redox protein partners for electron transport, has now led to better catalysts and processes with a greater understanding of process requirements and limitations for both in vitro and whole-cell systems. However, the discovery and development of unspecific peroxygenases (UPOs) has also recently provided valuable complementary technology to P450-catalyzed reactions. UPOs need only hydrogen peroxide to effect oxygenations but are hampered by their sensitivity to peroxide and also by limited selectivity. In this Perspective, we survey recent developments in the engineering of proteins, cells, and processes for oxygenations by these two groups of hemoproteins and evaluate their potential and relative merits for scalable reactions.

PMID:34604841 | PMC:PMC8479775 | DOI:10.1021/jacsau.1c00251


Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *